Susquehanna Fundamental Investments, LLC Incyte Corp Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$67.18 - $84.11 $1.46 Million - $1.82 Million	-21,663 Reduced 50.7%	21,061 $1.69 Million
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $2.46 Million - $3.08 Million	-37,200 Reduced 46.54%	42,724 $2.85 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $4.55 Million - $5.5 Million	68,949 Added 628.24%	79,924 $6.35 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $5.41 Million - $6.33 Million	-85,403 Reduced 88.61%	10,975 $806,000
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $2.18 Million - $2.67 Million	31,750 Added 49.13%	96,378 $6.63 Million
Q2 2021 Aug 11, 2021	BUY	$79.87 - $87.53 $4.61 Million - $5.05 Million	57,721 Added 835.69%	64,628 $5.44 Million
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $4.36 Million - $5.76 Million	-57,351 Reduced 89.25%	6,907 $561,000
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $5.19 Million - $6.28 Million	64,258 New	64,258 $5.59 Million

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.